Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Dominari Holdings Files $2 Billion Shelf to Support Strategic Expansion (PR Newswire) +++ DOMINARI Aktie +3,23%

COOPER COMPANIES Aktie

 >COOPER COS Aktienkurs 
53 EUR    -17.2%    (Tradegate)
Ask: 53 EUR / 104 Stück
Bid: 52 EUR / 106 Stück
Tagesumsatz: 588 Stück
Realtime Kurs von 8 bis 22 Uhr!
COOPER COS Aktie über LYNX handeln
>COOPER COS Performance
1 Woche: +1,6%
1 Monat: +2,4%
3 Monate: -9,9%
6 Monate: -26,1%
1 Jahr: -24,1%
laufendes Jahr: -27,0%
>COOPER COMPANIES Aktie
Name:  COOPER COMPANIES
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US2166485019 / A402VX
Symbol/ Ticker:  CP60 (Frankfurt) / COO (NASDAQ)
Kürzel:  FRA:CP60, ETR:CP60, CP60:GR, NASDAQ:COO
Index:  -
Webseite:  https://www.coopercos.com..
Profil:  The Cooper Companies Inc. is a global healthcare c..
>Volltext..
Marktkapitalisierung:  12689.17 Mio. EUR
Unternehmenswert:  14881.33 Mio. EUR
Umsatz:  3443.57 Mio. EUR
EBITDA:  968.17 Mio. EUR
Nettogewinn:  357.64 Mio. EUR
Gewinn je Aktie:  1.79 EUR
Schulden:  2232.33 Mio. EUR
Liquide Mittel:  100.33 Mio. EUR
Operativer Cashflow:  658.29 Mio. EUR
Bargeldquote:  0.11
Umsatzwachstum:  0.65%
Gewinnwachstum:  14.76%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Div. Historie:  26.07.23 - 0.0017293125€
20.01.23 - 0.0017293125€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  COOPER COMPANIES, COOPERCOMPANIES, COOPER COS
Letzte Datenerhebung:  28.08.25
>COOPER COS Kennzahlen
Aktien/ Unternehmen:
Aktien: 199.51 Mio. St.
Frei handelbar: 99.34%
Rückkaufquote: -0.16%
Mitarbeiter: 16000
Umsatz/Mitarb.: 0.21 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 26.05%
Bewertung:
KGV: 34.61
KGV lG: 18.04
KUV: 3.69
KBV: 1.72
PEG-Ratio: 1.67
EV/EBITDA: 15.37
Rentabilität:
Bruttomarge: 62.18%
Gewinnmarge: 10.39%
Operative Marge: 19%
Managementeffizenz:
Gesamtkaprendite: 3.39%
Eigenkaprendite: 5.15%
>COOPER COS Peer Group

Es sind 601 Aktien bekannt.
 
28.08.25 - 01:45
Here′s What Key Metrics Tell Us About The Cooper Companies (COO) Q3 Earnings (Zacks)
 
Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended July 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....
28.08.25 - 01:00
The Cooper Companies (COO) Q3 Earnings Beat Estimates (Zacks)
 
The Cooper Companies (COO) delivered earnings and revenue surprises of +2.80% and -0.50%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?...
27.08.25 - 23:48
Cooper Companies Posts 15% EPS Gain (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
27.08.25 - 22:42
The Cooper Companies, Inc. Q3 Profit Decreases, But Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - The Cooper Companies, Inc. (COO) announced earnings for third quarter that Decreased from last year but beat the Street estimates.The company's earnings came in at $98.3 mil......
27.08.25 - 22:18
CooperCompanies Announces Third Quarter 2025 Results (GlobeNewswire EN)
 
SAN RAMON, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2025....
26.08.25 - 23:42
The Cooper Companies Q3 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.08.25 - 17:30
How Much Upside is Left in The Cooper Companies (COO)? Wall Street Analysts Think 26.47% (Zacks)
 
The consensus price target hints at a 26.5% upside potential for The Cooper Companies (COO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term....
26.08.25 - 16:00
Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand (Zacks)
 
COO's Q3 results may top estimates, powered by strong demand for MyDay lenses, Biofinity gains and surgical product resilience despite fertility softness....
25.08.25 - 15:54
Do Wall Street Analysts Like Cooper Companies Stock? (Barchart)
 
Cooper Companies has been underperforming the broader market over the past year, but analysts still seem to be moderately optimistic about the stock's prospects....
22.08.25 - 16:45
The Cooper Companies (COO) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
 
Besides Wall Street's top-and-bottom-line estimates for The Cooper Companies (COO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2025....
20.08.25 - 17:30
The Cooper Companies (COO) Earnings Expected to Grow: What to Know Ahead of Next Week′s Release (Zacks)
 
The Cooper Companies (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
14.08.25 - 22:18
CooperCompanies to Participate in the Wells Fargo Healthcare Conference (GlobeNewswire EN)
 
SAN RAMON, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the Wells Fargo Healthcare Conference on Wednesday, September 3, 2025. Al White, President and CEO, will represent the Company in a session scheduled at 3:00 PM ET....
12.08.25 - 18:15
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies (Zacks)
 
Despite tariff headwinds and softer elective procedure demand, McKesson, Cardinal Health, West Pharmaceutical Services, and The Cooper Companies are positioned for steady gains in the dental supplies space....
05.08.25 - 19:45
All You Need to Know About The Cooper Companies (COO) Rating Upgrade to Buy (Zacks)
 
The Cooper Companies (COO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....
25.07.25 - 14:06
What to Expect From Cooper Companies€ Q3 2025 Earnings Report (Barchart)
 
Cooper Companies is expected to release its fiscal third-quarter earnings later next month, and analysts project a low double-digit profit growth....
24.07.25 - 22:18
CooperCompanies Announces Release Date for Third Quarter 2025 (GlobeNewswire EN)
 
SAN RAMON, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report third quarter 2025 financial results on Wednesday, August 27, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments....
02.07.25 - 16:00
COO Stock Declines Despite Strong Core Growth Amid Fertility Woes (Zacks)
 
The Cooper Companies grows margins and premium products, but fertility softness, inventory cuts, and tariffs weigh on the near-term outlook....
19.06.25 - 17:24
How is Cooper Companies′ Stock Performance Compared to Other Medical Instruments & Supplies Stocks? (Barchart)
 
Though Cooper Companies has underperformed relative to its industry peers over the past year, Wall Street analysts are moderately optimistic about its prospects....
17.06.25 - 15:30
Beyond The Numbers: 5 Analysts Discuss Cooper Companies Stock (Benzinga)
 
Latest Ratings for COO DateFirmActionFromTo Mar 2022Stephens & Co.MaintainsOverweight Jan 2022GuggenheimUpgradesNeutralBuy Dec 2021KeybancMaintainsOverweight View More Analyst Ratings for COO View the Latest Analyst Ratings read more...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Affen sind unsere Verwandten, und wir sollten stolz darauf sein. - Dr. Antal Festetics
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!